Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Columbia University, U.S.
Reports from the United States and South Korea describe recent advances in surgery research
September 13th, 2006
Data on surgery are outlined in reports from the United States and South Korea. Study 1: A pooled analysis from four randomized trials determined that treatment of intermediate lesions with drug-eluting stents appears safe and results in a marked reduction in clinical and angiographic restenosis compared to bare-metal stents. In a recent article published in the Journal of the American College of Cardiology, researchers explained, "To address the safety and efficacy of drug-eluting stents (DES) in the treatment of intermediate lesions, we performed a pooled analysis of four randomized DES versus bare-metal stent (BMS) trials and assessed...
Source: Telemedicine Business Week (2006-09-13)
|
